Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
New drug combo shows promise for rare thymic cancer
Disease control OngoingThis study tested a combination of two drugs, pembrolizumab and sunitinib, in 9 people with advanced thymic carcinoma that had spread or couldn't be removed and had stopped responding to standard chemotherapy. The goal was to see if the combination could shrink tumors. The approa…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
New combo shows promise for tough cancers
Disease control OngoingThis study tests a combination of two drugs—nivolumab (an immunotherapy that helps the immune system fight cancer) and temozolomide (a chemotherapy drug)—in people with small-cell lung cancer that has returned or stopped responding to treatment, or advanced neuroendocrine tumors.…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Vitamin a derivative joins immunotherapy in fight against advanced lung cancer
Disease control OngoingThis early-stage trial tests a combination of all-trans retinoic acid (ATRA), a drug made from vitamin A, and atezolizumab, an immunotherapy, in 18 adults with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 13, 2026 15:58 UTC